The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis
Open accessAbstract
IMPORTANCE: Schizophrenia is associated with an increased risk of type 2 diabetes. However, it is not clear whether schizophrenia confers an inherent risk for glucose dysregulation in the absence of the effects of chronic illness and long-term treatment. OBJECTIVE: To conduct a meta-analysis examining whether individuals with first-episode schizophrenia already exhibit alterations in glucose homeostasis compared with controls. DATA SOURCES: The EMBASE, MEDLINE, and PsycINFO databases were systematically searched for studies examining measures of glucose homeostasis in antipsychotic-naive individuals with first-episode schizophrenia compared with individuals serving as controls. STUDY SELECTION: Case-control studies reporting on fasting plasma glucose levels, plasma glucose levels after an oral glucose tolerance test, fasting plasma insulin levels, insulin resistance, and hemoglobin A1c (HbA1c) levels in first-episode antipsychotic-naive individuals with first-episode schizophrenia compared with healthy individuals serving as controls. Two independent investigators selected the studies. DATA EXTRACTION: Two independent investigators extracted study-level data for a random-effects meta-analysis. Standardized mean differences in fasting plasma glucose levels, plasma glucose levels after an oral glucose tolerance test, fasting plasma insulin levels, insulin resistance, and HbA1c levels were calculated. Sensitivity analyses examining the effect of body mass index, diet and exercise, race/ethnicity, and minimal (≤2 weeks) antipsychotic exposure were performed. DATA SYNTHESIS: Of 3660 citations retrieved, 16 case-control studies comprising 15 samples met inclusion criteria. The overall sample included 731 patients and 614 controls. Fasting plasma glucose levels (Hedges g = 0.20; 95% CI, 0.02 to 0.38; P = .03), plasma glucose levels after an oral glucose tolerance test (Hedges g = 0.61; 95% CI, 0.16 to 1.05; P = .007), fasting plasma insulin levels (Hedges g = 0.41; 95% CI, 0.09 to 0.72; P = .01), and insulin resistance (homeostatic model assessment of insulin resistance) (Hedges g = 0.35; 95% CI, 0.14 to 0.55; P = .001) were all significantly elevated in patients compared with controls. However, HbA1c levels (Hedges g = -0.08; CI, -0.34 to 0.18; P = .55) were not altered in patients compared with controls. CONCLUSIONS AND RELEVANCE: These findings show that glucose homeostasis is altered from illness onset in schizophrenia, indicating that patients are at increased risk of diabetes as a result. This finding has implications for the monitoring and treatment choice for patients with schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States
Yung, A. R., Yung, A. R., Pan Yuen, H., Mcgorry, P. D., Phillips, L. J., Kelly, D., Dell'olio, M., Francey, S. M., Cosgrave, E. M., Killackey, E., et al. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01714.x · Cited by 2,196
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Levy, J. C., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,013
Unwin, N. C. (2006) · Cited by 1,661
Glucose tolerance in adults after prenatal exposure to famine
Ravelli, A., van der Meulen, J., Michels, R., Osmond, C., Barker, D., Hales, C., & Bleker, O. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07244-9 · Cited by 1,606
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,082
Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913 · cited 2×
“Exclusion criteria were (1) studies only assessing diagnosis of type 1 or type 2 diabetes, (2) patients with multiple episodes of schizophrenia, (3) chronic antipsychotic treatment (>2 weeks’ lifetime exposure), (4) substance- or medicationinduced psychotic disorder, (5) physical comorbidity that may affect glucose ho…”
BackgroundMethodImpaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Rates of Adult Schizophrenia Following Prenatal Exposure to the Chinese Famine of 1959-1961
St Clair, D. (2005) · JAMA · doi:10.1001/jama.294.5.557 · Cited by 816
Schizophrenia After Prenatal Exposure to the Dutch Hunger Winter of 1944-1945
Susser, E. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120071010 · Cited by 726
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679 · cited 1×
“Exclusion criteria were (1) studies only assessing diagnosis of type 1 or type 2 diabetes, (2) patients with multiple episodes of schizophrenia, (3) chronic antipsychotic treatment (>2 weeks’ lifetime exposure), (4) substance- or medicationinduced psychotic disorder, (5) physical comorbidity that may affect glucose ho…”
BackgroundVancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., Rosenbaum, S., Gaughran, F., Lally, J., & Stubbs, B. (2016) · World Psychiatry · doi:10.1002/wps.20309 · Cited by 659
Symptom Assessment in Schizophrenic Prodromal States
Miller, T. J., McGlashan, T. H., Woods, S. W., Stein, K., Driesen, N., Corcoran, C. M., Hoffman, R., & Davidson, L. (1999) · Psychiatric Quarterly · doi:10.1023/a:1022034115078 · Cited by 642
Metabolic syndrome in people with schizophrenia: a review
DE HERT, M., SCHREURS, V., VANCAMPFORT, D., & VAN WINKEL, R. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00199.x · Cited by 634
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study
Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050599 · Cited by 619
Twenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Bowden, J., Tierney, J. F., Copas, A. J., & Burdett, S. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-41 · Cited by 553
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
Newcomer, J. W., Haupt, D. W., Fucetola, R., Melson, A. K., Schweiger, J. A., Cooper, B. P., & Selke, G. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.4.337 · Cited by 520
Stubbs, B., Firth, J., Berry, A., Schuch, F. B., Rosenbaum, S., Gaughran, F., Veronesse, N., Williams, J., Craig, T., Yung, A. R., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.017 · Cited by 379
Mitchell, A. J., Vancampfort, D., De Herdt, A., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs082 · Cited by 327
Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia
Spelman, L. M., Walsh, P. I., Sharifi, N., Collins, P., & Thakore, J. H. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02092.x · Cited by 318
Review of the operational definition for first‐episode psychosis
Breitborde, N. J. K., Srihari, V. H., & Woods, S. W. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2009.00148.x · Cited by 282
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Fernandez-Egea, E., Bernardo, M., Donner, T., Conget, I., Parellada, E., Justicia, A., Esmatjes, E., Garcia-Rizo, C., & Kirkpatrick, B. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.052605 · Cited by 242
Prenatal Malnutrition and Adult Schizophrenia: Further Evidence From the 1959-1961 Chinese Famine
Xu, M.-Q., Sun, W.-S., Liu, B.-X., Feng, G.-Y., Yu, L., Yang, L., He, G., Sham, P., Susser, E., St. Clair, D., et al. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn168 · Cited by 239
FAMILY HISTORY OF TYPE 2 DIABETES IN SCHIZOPHRENIC PATIENTS
Mukherjee, S., Schnur, D., & Reddy, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91392-5 · Cited by 224
Insulin and Insulin-Like Growth Factor-1 Abnormalities in Antipsychotic-Naive Schizophrenia
Venkatasubramanian, G., Chittiprol, S., Neelakantachar, N., Naveen, M. N., Thirthall, J., Gangadhar, B. N., & Shetty, K. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07020233 · Cited by 191
Diabetes mellitus and schizophrenia: Historical perspective
Kohen, D. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.47.s64 · Cited by 181
Arranz, B., Rosel, P., Ramírez, N., Dueñas, R., Fernández, P., Sanchez, J. M., Navarro, M. A., & San, L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1007 · Cited by 161
Tobacco Use Before, At, and After First-Episode Psychosis: A Systematic Meta-Analysis
Myles, N., Newall, H. D., Curtis, J., Nielssen, O., Shiers, D., & Large, M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07222 · Cited by 158
Borges, S., Gayer-Anderson, C., & Mondelli, V. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.12.025 · Cited by 153
Schizophrenia After Prenatal Exposure to the Dutch Hunger Winter of 1944-1945
Jones, P. B. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040077010 · Cited by 151
Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes
Lin, P., & Shuldiner, A. R. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.022 · Cited by 125
Sengupta, S. M., Parrilla-Escobar, M. A., Klink, R., Fathalli, F., Ng, Y. K., Stip, É., Baptista, T., MALLA, A. K., & Joober, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.013 · Cited by 121
Cohn, T. A., Remington, G. J., Zipursky, R. B., Azad, A., Connolly, P., & Wolever, T. M. S. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100608 · Cited by 111
Avoidable mortality in people with schizophrenia or bipolar disorder in England
Hoang, U., Goldacre, M. J., & Stewart, R. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12045 · Cited by 109
Metabolic syndrome in drug-naïve and drug-free patients with schizophrenia and in their siblings
Darçın, A. E., Çavuş, S. Y., Dılbaz, N., Kaya, H., & Dogan, E. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.05.004 · Cited by 108
Liu, Y., Li, Z., Zhang, M., Deng, Y., Yi, Z., & Shi, T. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s1-s17 · Cited by 103
van Winkel, R., Binder, M. D., Eyck, D. V., Hanssens, L., Hanssens, L., Wampers, M., Scheen, A. J., & Peuskens, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1002 · Cited by 92
Saddichha, S., Manjunatha, N., Ameen, S., & Akhtar, S. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01158.x · Cited by 86
Koivukangas, J., Tammelin, T., Kaakinen, M., Maki, P. M., Moilanen, I., Taanila, A. M., & Veijola, J. M. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.10.022 · Cited by 80
Howes, O. D., Bhatnagar, A., Gaughran, F., Amiel, S. A., Murray, R. M., & Pilowsky, L. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.361 · Cited by 80
Self-citationBeary, M., Hodgson, R., & Wildgust, H. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112440512 · Cited by 79 · cited 2×
“Exclusion criteria were (1) studies only assessing diagnosis of type 1 or type 2 diabetes, (2) patients with multiple episodes of schizophrenia, (3) chronic antipsychotic treatment (>2 weeks’ lifetime exposure), (4) substance- or medicationinduced psychotic disorder, (5) physical comorbidity that may affect glucose ho…”
BackgroundMethodChen, D. C., Du, X., Yin, G. Z., Yang, K., Nie, Y., Wang, N., Li, Y., Xiu, M., He, S. C., Yang, F. D., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291716001902 · Cited by 78
Chen, S., Broquères-You, D., Yang, G., Wang, Z., Li, Y., Wang, N., Zhang, X., Yang, F., & Tan, Y. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.08.056 · Cited by 67
Glucose disturbances in first-episode drug-naïve schizophrenia: Relationship to psychopathology
Zhang, X. Y., Chen, D.-C., Tan, Y.-L., An, H., Zunta‐Soares, G. B., Huang, X., & Soares, J. C. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.005 · Cited by 66
Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway
García‐Rizo, C., Kirkpatrick, B. W., Fernández-Egea, E., Oliveira, C., & Bernardo, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.001 · Cited by 66
Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients
Dasgupta, A., Singh, O. P., Rout, J. K., Saha, T., & Mandal, S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.011 · Cited by 65
The pathology of mind. A study of its distempers, deformities and disorders
Maudsley, H. (2002) · Revista Latinoamericana de Psicopatologia Fundamental · doi:10.1590/1415-47142002002011 · Cited by 63
Petrikis, P., Tigas, S. K., Tzallas, A. T., Papadopoulos, I. A., Skapinakis, P., & Mavreas, V. G. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.041 · Cited by 60
Wani, R. A., Dar, M. A., Margoob, M. A., Rather, Y. H., Haq, I., & Shah, M. S. (2014) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.143182 · Cited by 48
Sun, H.-Q., Li, S.-X., Chen, F.-B., Zhang, Y., Li, P., Jin, M., Sun, Y., Wang, F., Mi, W.-F., Shi, L., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.013 · Cited by 42
Tai, E. S., Lim, S. C., Tan, B. Y., Chew, S. K., Heng, D., & Tan, C. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00382.x · Cited by 38
Common familial risk factors for schizophrenia and diabetes mellitus
Foley, D. L., Mackinnon, A. J., Morgan, V. A., Watts, G. F., Castle, D. J., Waterreus, A. J., & Galletly, C. A. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415595715 · Cited by 33
Welie, H., Derks, E. M., Verweij, K. H. W., de Valk, H. W., Kahn, R. S., & Cahn, W. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.011 · Cited by 29
Juutinen, J., Hakko, H. H., Meyer‐Rochow, V. B., Räsänen, P. K., & Timonen, M. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.06.002 · Cited by 12
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Self-citationPillinger, T., McCutcheon, R. A., Vano, L., Mizuno, Y., Arumuham, A., Hindley, G., Beck, K., Natesan, S., Efthimiou, O., Cipriani, A., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30416-x · Cited by 1,090
Correll, C. U., Solmi, M., Croatto, G., Schneider, L. K., Rohani‐Montez, S. C., Fairley, L., Smith, N., Bitter, I., Gorwood, P., Taipale, H., et al. (2022) · World Psychiatry · doi:10.1002/wps.20994 · Cited by 686
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Self-citationMetabolic syndrome in psychiatric patients: overview, mechanisms, and implications
Penninx, B. W. J. H., & Lange, S. M. M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/bpenninx · Cited by 566
Metadata
- Authors
- Pillinger, T., Beck, K., Gobjila, C., Donocik, J. G., Jauhar, S., & Howes, O. D.
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2017-03-01
- Volume
- 74
- Issue
- 3
- Pages
- 261
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2572252150
- Cited by
- 457
- References
- 67
- FWCI
- 35.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.